Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04151563
Title A Phase 1/2 Study Evaluating Multiple Nivolumab Combination Therapy in Participants With Stage IV Non-small Cell Lung Cancer That Has Spread or Has Reoccurred After Failure of Chemotherapy and Immunotherapy
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

Therapies

Lucitanib + Nivolumab

Docetaxel

Cabozantinib + Nivolumab

Cabozantinib + Ipilimumab + Nivolumab

Docetaxel + Nivolumab

Docetaxel + Nivolumab + Ramucirumab

Age Groups: senior | adult
Covered Countries USA | BEL

Facility Status City State Zip Country Details
Local Institution Detroit Michigan 48201 United States Details
Local Institution Ciudad Autónoma De Buenos Aires Buenos Aires 1426 Argentina Details
Local Institution Buenos Aires Distrito Federal 1431 Argentina Details
Local Institution Buenos Aires Distrito Federal C1199ABB Argentina Details
Local Institution Caba Distrito Federal 1430 Argentina Details
Local Institution Capital Distrito Federal C1280 Argentina Details
Local Institution Charleroi 6000 Belgium Details
Local Institution Gilly 6060 Belgium Details
Local Institution Leuven 3000 Belgium Details
Local Institution Copenhagen Ø 2100 Denmark Details
Local Institution Athens 11527 Greece Details
Local Institution Neo Faliro 18547 Greece Details
Local Institution Torreon Coahuila 27010 Mexico Details
Local Institution Ciudad de México Distrito Federal 03240 Mexico Details
Local Institution Zapopan Jalisco 44280 Mexico Details
Local Institution Heroica Puebla de Zaragoza Puebla 72530 Mexico Details
Local Institution Amsterdam 1066 CX Netherlands Details
Local Institution Rotterdam 3015 GD Netherlands Details
Local Institution Oslo 0379 Norway Details
Local Institution Warszawa Mazowieckie 02-781 Poland Details
Local Institution Krakow 30-688 Poland Details
Local Institution Craiova 200347 Romania Details
Local Institution Timisoara 300696 Romania Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field